eyeforpharma Market Access & Real World Evidence EU Summit
May 10-11, 2016
Novotel Amsterdam City, Amsterdam, NL
Andrew Butcher is speaking on “Balancing cost effectiveness with economics – alleviate funding constraints on HTA approved drugs by managing diverging stakeholder perspectives.” CRA is also sponsoring the conference.
For more information on the event, click here.